Revenue
2025
Drugs Made In America Acquisition Corp. (DMAA)
Price$10.76Cached quote
Net income
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2024
2025
Financial statements
| 2025 | 2024 | |
|---|---|---|
| Revenue | $0 | — |
| Operating expenses | $141,976 | — |
| Operating income | −$2.8M | — |
| EBITDA | −$2.8M | — |
| Net income | $5.9M | −$279,845 |
| Basic EPSper basic share | $0.19 | -$0.03 |
| Diluted EPSper diluted share | $0.19 | -$0.03 |
Owners
Reported shareholders
≈39.08%of listed shares
Stockwell Lynn4.19M shares · Feb 18, 2025
View holders
| Holder | % owned |
|---|---|
Stockwell Lynn | ≈39.08%4.19M shares |
Drugs Made In America Acquisition LLC | ≈39.08%4.19M shares |
MIZUHO SECURITIES USA LLC | 37.97%4.07M shares |
Karpus Management, Inc. | 23.40%2.51M shares |
Polar Asset Management Partners Inc. | 10.69%1.15M shares |
GLAZER CAPITAL, LLC | 9.33%999.9K shares |
WOLVERINE ASSET MANAGEMENT LLC | 7.76%832.09K shares |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7.55%809.05K shares |
First Trust Capital Management L.P. | 7.34%786.46K shares |
HEIGHTS CAPITAL MANAGEMENT, INC | 6.05%648.08K shares |
Westchester Capital Management, LLC | 5.43%581.79K shares |
Clear Street Group Inc. | 3.57%382.44K shares |
ARISTEIA CAPITAL, L.L.C. | 3.27%350K shares |
SONA ASSET MANAGEMENT (US) LLC | 1.52%162.8K shares |
RLH Capital LLC | 1.08%115.61K shares |
Logan Stone Capital, LLC | 1.03%109.96K shares |
TORONTO DOMINION BANK | 0.93%100K shares |
Worman Glenn C. | ≈0.93%100K shares |
Prasad Sridhar G. | ≈0.93%100K shares |
Shulgan Myron W. | ≈0.93%100K shares |
Percentages use 10.72M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Reported positions exceed 100% in total, so the circle shows the selected holder only.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 18, 2025Form 4 | Drugs Made In America Acquisition LLCTenPercentOwner | BuyOrdinary shares | 30.0K | — | — | 4.19M |
| Feb 18, 2025Form 4 | Drugs Made In America Acquisition LLCTenPercentOwner | BuyRights to receive ordinary shares · derivative | 30.0K | — | — | 430.0K |
| Feb 18, 2025Form 4 | Stockwell LynnCEO and Exe. Chair of Board | BuyOrdinary shares · indirect | 30.0K | — | — | 4.19M |
| Feb 18, 2025Form 4 | Stockwell LynnCEO and Exe. Chair of Board | BuyRights to receive ordinary shares · derivative · indirect | 30.0K | — | — | 430.0K |
| Jan 29, 2025Form 4 | Drugs Made In America Acquisition LLCTenPercentOwner | SellOrdinary shares | 5.70M | — | — | 4.16M |